Events

HACRO – the Hellenic Association of Contract Research Organizations – was honoured to support, under its auspices, the 3rd Synergies Forum on Cancer: Policy, Research & Funding Strategies, organised by the Hellenic Cancer Federation (ELLOK) and held in Athens from 29 June to 1 July 2026. As part of the Forum, HACRO President Evangelia (Lia) Koraki participated in the panel discussion “Bringing Cancer Innovation to Patients: Clinical Trials and Translational Pipelines,” highlighting the strategic role of clinical research in Greece and the evolving European agenda for innovation. During her presentation, Ms Koraki emphasised that Europe is redefining the role ...

HACRO – the Hellenic Association of Contract Research Organizations – participated in the 10th Panhellenic Conference “Molecular Medicine: From the Laboratory to Clinical Practice – Challenges and Questions X,” held on 25–27 June 2026, with a presentation by HACRO President Evangelia (Lia) Koraki during the session “Clinical Trials in Greece – The Need for New Therapies and Growth.” During her presentation, Ms Koraki outlined the significant regulatory developments currently underway in Greece, alongside the European Union’s evolving agenda for clinical trials, biotechnology and the life sciences. She highlighted that Greece is now presented with a unique opportunity to strengthen ...

The HACRO – Hellenic Association of CROs is pleased to congratulate its President, Mrs. Evangelia (Lia) Koraki, on her election to the Executive Board of the European CRO Federation (EUCROF). The election took place during the EUCROF Spring General Assembly, held in Sofia, Bulgaria, on 4–5 June 2026, bringing together representatives from across Europe to discuss key developments, priorities and initiatives shaping the future of clinical research in Europe.During the meeting, four new members were elected to the EUCROF Executive Board. Alongside Evangelia (Lia) Koraki, the newly elected Board members are Doris Neuhauser, Jean-Sébastien Gosuin and Philip Raeth. This election ...

On 20 May, marking World Clinical Trials Day, a press conference was held at the Ministry of Health to officially launch the awareness campaign “I Participate Because I Have… Knowledge – Benefit – Trust.” The event brought together Minister of Health Adonis Georgiadis, Secretary General for Health Services Lilian Venetia Vildiridi, EOF President Spyros Sapounas, as well as representatives of patient organisations, the scientific community and the pharmaceutical industry, highlighting the importance of collaboration in advancing clinical research in Greece. The campaign is led by the Alliance for Promoting the Value of Clinical Trials, a joint initiative of the ...

HACRO – the Hellenic Association of Contract Research Organizations – participated in the High-Level Policy Round Table “IBD Greece 2030”, held on 19 May 2026, represented by its President Evangelia (Lia) Koraki in the panel discussion “Pharmaceutical Innovation, Clinical Trials and Inflammatory Bowel Disease (IBD).” During the discussion, Ms Koraki highlighted that Greece is gradually moving beyond a period of fragmented initiatives towards a more coherent national strategy for clinical research. She emphasised that the next critical step is to ensure that this positive momentum is translated into long-term, measurable outcomes that strengthen the healthcare system, foster innovation and ...

On World Clinical Trials Day, the Alliance for Promoting the Value of Clinical Trials—bringing together the Greek Patients Association, HACRO (Hellenic Association of Contract Research Organizations) and the Athens Medical Association—is proud to launch its new national awareness campaign, “I Participate Because I Have… Knowledge – Benefit – Trust.” The campaign aims to provide patients with reliable, evidence-based information about clinical trials, helping them better understand the clinical research process, the safeguards in place and the potential benefits of participation. By promoting knowledge and transparency, the initiative seeks to strengthen public trust and encourage informed decision-making. The campaign is ...